Please enable JavaScript to continue using this application.

Compare $ATRA vs $ICCC | Chartloom

Compare

$ATRA vs $ICCC

Atara Biotherapeutics Inc · ImmuCell Corp

ATRA

Atara Biotherapeutics Inc

ICCC

ImmuCell Corp

Compare $ATRA vs $ICCC

Comparing Atara Biotherapeutics Inc and ImmuCell Corp

ATRAAtara Biotherapeutics Inc

ICCCImmuCell Corp

ATRAAtara Biotherapeutics Inc

Market cap

$85M

P/E (TTM)

—

Forward P/E (NTM)

14.78x

Forward P/S (NTM)

2.47x

Rev growth (TTM)

-96.7%

YTD performance

-46.7%

52W performance

-40.2%

FCF yield

-25.6%

ICCCImmuCell Corp

Market cap

$89M

P/E (TTM)

114.37x

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

8.5%

YTD performance

65.5%

52W performance

48.7%

FCF yield

4.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ATRA

ICCC

Detailed metrics comparison

ATRA

Atara Biotherapeutics Inc

ICCC

ImmuCell Corp

Market Cap

ATRA$85M

ICCC$89M

Enterprise Value

ATRA$124M

ICCC$88M

Price

ATRA$9.48

ICCC$9.80

P/E Ratio

ATRAN/A

ICCC114.37x

P/S Ratio

ATRA13.79x

ICCC2.89x

EV/Sales

ATRA19.98x

ICCC2.87x

EV/EBITDA

ATRA3.51x

ICCC14.10x

P/B Ratio

ATRA12.86x

ICCC2.82x

P/FCF Ratio

ATRAN/A

ICCC21.04x

EV/FCF

ATRA-5.65x

ICCC20.91x

PEG Ratio

ATRAN/A

ICCCN/A

Forward P/E (NTM)

ATRA14.78x

ICCCN/A

Forward P/S (NTM)

ATRA2.47x

ICCCN/A

Revenue (TTM)

ATRA$6M

ICCC$31M

Revenue Growth (YoY)

ATRA-96.7%

ICCC8.5%

Forward Rev Growth

ATRA1983.2%

ICCC0.0%

Gross Margin (TTM)

ATRA91.4%

ICCC40.3%

Operating Margin (TTM)

ATRA0.0%

ICCC3.9%

EBITDA Margin (TTM)

ATRA-194.7%

ICCC20.4%

Net Margin (TTM)

ATRA-269.4%

ICCC2.6%

FCF Margin (TTM)

ATRA-353.5%

ICCC13.7%

Net Income (TTM)

ATRA$-17M

ICCC$787K

FCF (TTM)

ATRA$-22M

ICCC$4M

EPS (TTM)

ATRA-$1.11

ICCC$0.09

ROE (TTM)

ATRA-31542.0%

ICCC2.7%

ROA (TTM)

ATRA-7301.0%

ICCC1.8%

ROIC (TTM)

ATRA-30684.0%

ICCC2.1%

Cash

ATRA$3M

ICCC$9M

Debt

ATRA$42M

ICCC$8M

Net Cash/Debt

ATRA$-38M

ICCC$557K

Current Ratio (TTM)

ATRA1.98x

ICCC4.75x

Quick Ratio (TTM)

ATRA1.98x

ICCC2.65x

Debt/Equity (TTM)

ATRA0.12x

ICCC0.26x

Debt/Assets (TTM)

ATRA0.0%

ICCC0.0%

Interest Coverage (TTM)

ATRAN/A

ICCCN/A

Net Debt/EBITDA (TTM)

ATRA0.00x

ICCC0.00x

Beta

ATRA0.31

ICCC0.60

52W Performance

ATRA-40.2%

ICCC48.7%

YTD Performance

ATRA-46.7%

ICCC65.5%

% from 52W High

ATRA-50.5%

ICCC-19.0%

% from 52W Low

ATRA141.8%

ICCC116.8%

Asset Turnover (TTM)

ATRA0.27x

ICCC0.69x

FCF Yield (TTM)

ATRA-25.6%

ICCC4.8%

Earnings Yield (TTM)

ATRA-19.5%

ICCC0.9%

Dividend Yield (TTM)

ATRAN/A

ICCCN/A

Rule of 40

ATRA-450.2

ICCC22.2

EV/GP/RG

ATRA0.05

ICCCN/A

Ticker research

View ATRA research View ICCC research

Metric	ATRA Atara Biotherapeutics Inc	ICCC ImmuCell Corp
Market & Valuation
Market Cap	$85M	$89M
Enterprise Value	$124M	$88M
Price	$9.48	$9.80
P/E Ratio	N/A	114.37x
P/S Ratio	13.79x	2.89x
EV/Sales	19.98x	2.87x
EV/EBITDA	3.51x	14.10x
P/B Ratio	12.86x	2.82x
P/FCF Ratio	N/A	21.04x
EV/FCF	-5.65x	20.91x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	14.78x	N/A
Forward P/S (NTM)	2.47x	N/A
Revenue & Growth
Revenue (TTM)	$6M	$31M
Revenue Growth (YoY)	-96.7%	8.5%
Forward Rev Growth	1983.2%	0.0%
Profitability
Gross Margin (TTM)	91.4%	40.3%
Operating Margin (TTM)	0.0%	3.9%
EBITDA Margin (TTM)	-194.7%	20.4%
Net Margin (TTM)	-269.4%	2.6%
FCF Margin (TTM)	-353.5%	13.7%
Net Income (TTM)	$-17M	$787K
FCF (TTM)	$-22M	$4M
EPS (TTM)	-$1.11	$0.09
ROE (TTM)	-31542.0%	2.7%
ROA (TTM)	-7301.0%	1.8%
ROIC (TTM)	-30684.0%	2.1%
Financial Health
Cash	$3M	$9M
Debt	$42M	$8M
Net Cash/Debt	$-38M	$557K
Current Ratio (TTM)	1.98x	4.75x
Quick Ratio (TTM)	1.98x	2.65x
Debt/Equity (TTM)	0.12x	0.26x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.31	0.60
52W Performance	-40.2%	48.7%
YTD Performance	-46.7%	65.5%
% from 52W High	-50.5%	-19.0%
% from 52W Low	141.8%	116.8%
Efficiency & Yields
Asset Turnover (TTM)	0.27x	0.69x
FCF Yield (TTM)	-25.6%	4.8%
Earnings Yield (TTM)	-19.5%	0.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-450.2	22.2
EV/GP/RG	0.05	N/A
Ticker research	View ATRA research	View ICCC research

Valuation

P/E Ratio

ICCC

114.37x

P/S Ratio

ICCC

2.89x

ATRA

13.79x

EV/FCF

ATRA

-5.65x

ICCC

20.91x

Growth & revenue

Revenue Growth TTM

ICCC

8.5%

ATRA

-96.7%

Forward Revenue Growth

ATRA

1983.2%

ICCC

0.0%

Profitability & performance

Gross Margin

ATRA

91.4%

ICCC

40.3%

ROE

ICCC

2.7%

ATRA

-31542.0%

FCF Yield %

ICCC

4.8%

ATRA

-25.6%

52-Week Performance

ICCC

48.7%

ATRA

-40.2%

Detailed metrics comparison

ATRA

Atara Biotherapeutics Inc

ICCC

ImmuCell Corp

Market Cap

ATRA$85M

ICCC$89M

Enterprise Value

ATRA$124M

ICCC$88M

Price

ATRA$9.48

ICCC$9.80

P/E Ratio

ATRAN/A

ICCC114.37x

P/S Ratio

ATRA13.79x

ICCC2.89x

EV/Sales

ATRA19.98x

ICCC2.87x

EV/EBITDA

ATRA3.51x

ICCC14.10x

P/B Ratio

ATRA12.86x

ICCC2.82x

P/FCF Ratio

ATRAN/A

ICCC21.04x

EV/FCF

ATRA-5.65x

ICCC20.91x

PEG Ratio

ATRAN/A

ICCCN/A

Forward P/E (NTM)

ATRA14.78x

ICCCN/A

Forward P/S (NTM)

ATRA2.47x

ICCCN/A

Revenue (TTM)

ATRA$6M

ICCC$31M

Revenue Growth (YoY)

ATRA-96.7%

ICCC8.5%

Forward Rev Growth

ATRA1983.2%

ICCC0.0%

Gross Margin (TTM)

ATRA91.4%

ICCC40.3%

Operating Margin (TTM)

ATRA0.0%

ICCC3.9%

EBITDA Margin (TTM)

ATRA-194.7%

ICCC20.4%

Net Margin (TTM)

ATRA-269.4%

ICCC2.6%

FCF Margin (TTM)

ATRA-353.5%

ICCC13.7%

Net Income (TTM)

ATRA$-17M

ICCC$787K

FCF (TTM)

ATRA$-22M

ICCC$4M

EPS (TTM)

ATRA-$1.11

ICCC$0.09

ROE (TTM)

ATRA-31542.0%

ICCC2.7%

ROA (TTM)

ATRA-7301.0%

ICCC1.8%

ROIC (TTM)

ATRA-30684.0%

ICCC2.1%

Cash

ATRA$3M

ICCC$9M

Debt

ATRA$42M

ICCC$8M

Net Cash/Debt

ATRA$-38M

ICCC$557K

Current Ratio (TTM)

ATRA1.98x

ICCC4.75x

Quick Ratio (TTM)

ATRA1.98x

ICCC2.65x

Debt/Equity (TTM)

ATRA0.12x

ICCC0.26x

Debt/Assets (TTM)

ATRA0.0%

ICCC0.0%

Interest Coverage (TTM)

ATRAN/A

ICCCN/A

Net Debt/EBITDA (TTM)

ATRA0.00x

ICCC0.00x

Beta

ATRA0.31

ICCC0.60

52W Performance

ATRA-40.2%

ICCC48.7%

YTD Performance

ATRA-46.7%

ICCC65.5%

% from 52W High

ATRA-50.5%

ICCC-19.0%

% from 52W Low

ATRA141.8%

ICCC116.8%

Asset Turnover (TTM)

ATRA0.27x

ICCC0.69x

FCF Yield (TTM)

ATRA-25.6%

ICCC4.8%

Earnings Yield (TTM)

ATRA-19.5%

ICCC0.9%

Dividend Yield (TTM)

ATRAN/A

ICCCN/A

Rule of 40

ATRA-450.2

ICCC22.2

EV/GP/RG

ATRA0.05

ICCCN/A

Ticker research

View ATRA research View ICCC research

Metric	ATRA Atara Biotherapeutics Inc	ICCC ImmuCell Corp
Market & Valuation
Market Cap	$85M	$89M
Enterprise Value	$124M	$88M
Price	$9.48	$9.80
P/E Ratio	N/A	114.37x
P/S Ratio	13.79x	2.89x
EV/Sales	19.98x	2.87x
EV/EBITDA	3.51x	14.10x
P/B Ratio	12.86x	2.82x
P/FCF Ratio	N/A	21.04x
EV/FCF	-5.65x	20.91x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	14.78x	N/A
Forward P/S (NTM)	2.47x	N/A
Revenue & Growth
Revenue (TTM)	$6M	$31M
Revenue Growth (YoY)	-96.7%	8.5%
Forward Rev Growth	1983.2%	0.0%
Profitability
Gross Margin (TTM)	91.4%	40.3%
Operating Margin (TTM)	0.0%	3.9%
EBITDA Margin (TTM)	-194.7%	20.4%
Net Margin (TTM)	-269.4%	2.6%
FCF Margin (TTM)	-353.5%	13.7%
Net Income (TTM)	$-17M	$787K
FCF (TTM)	$-22M	$4M
EPS (TTM)	-$1.11	$0.09
ROE (TTM)	-31542.0%	2.7%
ROA (TTM)	-7301.0%	1.8%
ROIC (TTM)	-30684.0%	2.1%
Financial Health
Cash	$3M	$9M
Debt	$42M	$8M
Net Cash/Debt	$-38M	$557K
Current Ratio (TTM)	1.98x	4.75x
Quick Ratio (TTM)	1.98x	2.65x
Debt/Equity (TTM)	0.12x	0.26x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.31	0.60
52W Performance	-40.2%	48.7%
YTD Performance	-46.7%	65.5%
% from 52W High	-50.5%	-19.0%
% from 52W Low	141.8%	116.8%
Efficiency & Yields
Asset Turnover (TTM)	0.27x	0.69x
FCF Yield (TTM)	-25.6%	4.8%
Earnings Yield (TTM)	-19.5%	0.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-450.2	22.2
EV/GP/RG	0.05	N/A
Ticker research	View ATRA research	View ICCC research